Vyleesi (bremelanotide injection) is the first and only FDA-approved as-needed treatment for women experiencing low libido associated with HSDD (hypoactive sexual desire disorder). It was approved by the FDA on June 21, 2019.
Vyleesi is for women who have not gone through menopause, who have not had problems with low sexual desire in the past, and who have low sexual desire no matter the type of sexual activity, the situation, or the sexual partner. Women with HSDD have low sexual desire that is troubling to them. Their low sexual desire is not due to:
- a medical or mental health problem
- problems in the relationship
- medicine or other drug use
Do not use if you have:
- high blood pressure that is not controlled (uncontrolled hypertension)
- known heart (cardiovascular) disease